Guerbet SA
PAR:GBT
Relative Value
The Relative Value of one
GBT
stock under the Base Case scenario is
48.96
EUR.
Compared to the current market price of 9.2 EUR,
Guerbet SA
is
Undervalued by 81%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
GBT Competitors Multiples
Guerbet SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Guerbet SA
PAR:GBT
|
115.9m EUR | 0.1 | 14.9 | 3.4 | 10.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.3 | 37.5 | 27.2 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
57.3B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.8B CHF | 3.5 | 37.4 | 14.4 | 28 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
95.5B DKK | 3.5 | 24.1 | 12.8 | 15.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.5B USD | 3.1 | 30 | 12.9 | 17.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 32.9 | 11.5 | 18 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.5 | 16.8 | 54.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.4B CNY | 8.7 | 23.9 | 21.5 | 21.5 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38.8B CNY | 3.9 | 22.8 | 34 | 34 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
836.8B JPY | 6.4 | 47.3 | 22.3 | 30.3 |